These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 34492460)

  • 21. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion.
    Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S
    J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ellagic acid-Fe@BSA nanoparticles for endogenous H
    Tian Q; An L; Tian Q; Lin J; Yang S
    Theranostics; 2020; 10(9):4101-4115. PubMed ID: 32226542
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemodynamic therapy agent optimized mesoporous TiO
    Chen J; Zhang J; Wei X; Zhang Y; Hu J; Liu H; Zhang S; Yang B
    J Colloid Interface Sci; 2023 Nov; 650(Pt B):1773-1785. PubMed ID: 37506418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A biocompatible theranostic agent based on stable bismuth nanoparticles for X-ray computed tomography/magnetic resonance imaging-guided enhanced chemo/photothermal/chemodynamic therapy for tumours.
    Zhao H; Wang J; Li X; Li Y; Li C; Wang X; Wang J; Guan S; Xu Y; Deng G; Chen Y; Lu J; Liu X
    J Colloid Interface Sci; 2021 Dec; 604():80-90. PubMed ID: 34265694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biodegradable Silica-Based Nanotheranostics for Precise MRI/NIR-II Fluorescence Imaging and Self-Reinforcing Antitumor Therapy.
    Zheng Z; Jia Z; Qu C; Dai R; Qin Y; Rong S; Liu Y; Cheng Z; Zhang R
    Small; 2021 Mar; 17(10):e2006508. PubMed ID: 33569918
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pH-responsive platform combining chemodynamic therapy with limotherapy for simultaneous bioimaging and synergistic cancer therapy.
    Xiao J; Zhang G; Xu R; Chen H; Wang H; Tian G; Wang B; Yang C; Bai G; Zhang Z; Yang H; Zhong K; Zou D; Wu Z
    Biomaterials; 2019 Sep; 216():119254. PubMed ID: 31195303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eradication of solid tumors by chemodynamic theranostics with H
    Wang N; Zeng Q; Zhang R; Xing D; Zhang T
    Theranostics; 2021; 11(5):2334-2348. PubMed ID: 33500728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor Microenvironment Stimuli-Responsive Fluorescence Imaging and Synergistic Cancer Therapy by Carbon-Dot-Cu
    Sun S; Chen Q; Tang Z; Liu C; Li Z; Wu A; Lin H
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):21041-21048. PubMed ID: 32914924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. H
    Xiao Z; Zuo W; Chen L; Wu L; Liu N; Liu J; Jin Q; Zhao Y; Zhu X
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):43925-43936. PubMed ID: 34499485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A GSH-Gated DNA Nanodevice for Tumor-Specific Signal Amplification of microRNA and MR Imaging-Guided Theranostics.
    Yan N; Lin L; Xu C; Tian H; Chen X
    Small; 2019 Oct; 15(41):e1903016. PubMed ID: 31423737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomimetic Yolk-Shell Nanocatalysts for Activatable Dual-Modal-Image-Guided Triple-Augmented Chemodynamic Therapy of Cancer.
    Pan Y; Zhu Y; Xu C; Pan C; Shi Y; Zou J; Li Y; Hu X; Zhou B; Zhao C; Gao Q; Zhang J; Wu A; Chen X; Li J
    ACS Nano; 2022 Nov; 16(11):19038-19052. PubMed ID: 36315056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H
    Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J
    Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface curvature-induced oriented assembly of sushi-like Janus therapeutic nanoplatform for combined chemodynamic therapy.
    Ma Y; Liu M; Hou M; Kou Y; Wang W; Zhao T; Li X
    J Nanobiotechnology; 2023 Nov; 21(1):425. PubMed ID: 37968644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Metabolic Multistage Glutathione Depletion Used for Tumor-Specific Chemodynamic Therapy.
    Huang Y; Wu S; Zhang L; Deng Q; Ren J; Qu X
    ACS Nano; 2022 Mar; 16(3):4228-4238. PubMed ID: 35213138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-targeting nanotheranostics for MRI-guided enhanced chemodynamic therapy of hepatoma
    Liu J; Qu H; Hang L; Sun Y; Li W; Chen Y; Li H; Wen W; Feng Y; Jiang G
    Dalton Trans; 2023 Nov; 52(44):16433-16441. PubMed ID: 37872809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Three-pronged attacks by hybrid nanoassemblies involving a natural product, carbon dots, and Cu
    Lai CM; Xu J; Zhang BC; Li DM; Shen JW; Yu SJ; Shao JW
    J Colloid Interface Sci; 2023 Nov; 650(Pt A):526-540. PubMed ID: 37423180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fe(III)-Naphthazarin Metal-Phenolic Networks for Glutathione-Depleting Enhanced Ferroptosis-Apoptosis Combined Cancer Therapy.
    Liu Z; Liu S; Liu B; Bian Y; Yuan M; Yang C; Meng Q; Chen C; Ma P; Lin J
    Small; 2023 May; 19(19):e2207825. PubMed ID: 36772903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Organic disulfide-modified folate carbon dots for tumor-targeted synergistic chemodynamic/photodynamic therapy.
    Tang S; Li G; Zhang H; Bao Y; Wu X; Yan R; Wang Z; Jin Y
    Biomater Sci; 2023 May; 11(9):3128-3143. PubMed ID: 36919663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. H
    Tang Z; Jiang S; Tang W; He Q; Wei H; Jin C; Wang S; Zhang H
    Mol Pharm; 2023 Mar; 20(3):1717-1728. PubMed ID: 36809003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copperphosphotungstate Doped Polyanilines Nanorods for GSH-Depletion Enhanced Chemodynamic/NIR-II Photothermal Synergistic Therapy.
    Ye S; Xiao H; Chen J; Zhang D; Qi L; Peng T; Gao Y; Zhang Q; Qu J; Wang L; Liu R
    Int J Nanomedicine; 2023; 18():1245-1257. PubMed ID: 36937549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.